Retour
41
Également cotée sous
ANSLY
OTC
Fourchette du Jour
22,74 €
22,74 €
Fourchette 52 Semaines
18,00 €
25,00 €
Volume
2 000
Moyenne 50J / 200J
22,83 €
/
20,36 €
Clôture Précédente
22,74 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 32,3 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | 5,3 | 3,8 |
| Net Margin % | 5,1 | 3,9 |
| Rev Growth 5Y % | -0,5 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,80 €
1,75 € – 1,87 €
|
2,3 B | 5 |
| FY2028 |
1,66 €
1,61 € – 1,72 €
|
2,2 B | 6 |
| FY2027 |
1,56 €
1,52 € – 1,62 €
|
2,2 B | 5 |
Points Clés
Revenue declined -0,45% annually over 5 years
Earnings grew 32,81% over the past year
Debt/Equity of 0,41 — conservative balance sheet
Generating 170,00M in free cash flow
P/E of 32,30 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24,16%
Croissance
Revenue Growth (5Y)
-0,45%
Revenue (1Y)23,71%
Earnings (1Y)32,81%
FCF Growth (3Y)33,51%
Qualité
Return on Equity
5,27%
ROIC2,95%
Net Margin5,07%
Op. Margin5,45%
Sécurité
Debt / Equity
0,41
Current Ratio2,13
Interest Coverage2,32
Valorisation
P/E Ratio
32,30
P/B Ratio1,67
EV/EBITDA35,28
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23,71% | Revenue Growth (3Y) | 10,72% |
| Earnings Growth (1Y) | 32,81% | Earnings Growth (3Y) | -17,23% |
| Revenue Growth (5Y) | -0,45% | Earnings Growth (5Y) | -19,89% |
| Profitability | |||
| Revenue (TTM) | 2,00B | Net Income (TTM) | 101,60M |
| ROE | 5,27% | ROA | 3,06% |
| Gross Margin | 41,18% | Operating Margin | 5,45% |
| Net Margin | 5,07% | Free Cash Flow (TTM) | 170,00M |
| ROIC | 2,95% | FCF Growth (3Y) | 33,51% |
| Safety | |||
| Debt / Equity | 0,41 | Current Ratio | 2,13 |
| Interest Coverage | 2,32 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 32,30 | P/B Ratio | 1,67 |
| P/S Ratio | 1,64 | PEG Ratio | 1,27 |
| EV/EBITDA | 35,28 | Dividend Yield | 0,02% |
| Market Cap | 3,28B | Enterprise Value | 3,85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,00B | 1,62B | 1,63B | 1,85B | 2,04B |
| Net Income | 101,60M | 76,50M | 148,30M | 158,70M | 246,70M |
| EPS (Diluted) | 0,71 | 0,59 | 1,15 | 1,18 | 1,91 |
| Gross Profit | 825,00M | 624,80M | 604,22M | 625,19M | 807,21M |
| Operating Income | 109,10M | 129,30M | 210,50M | 236,60M | 343,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,32B | 3,24B | 2,52B | 2,51B | 2,74B |
| Total Liabilities | 1,34B | 1,33B | 913,07M | 949,48M | 1,17B |
| Shareholders' Equity | 1,96B | 1,89B | 1,60B | 1,54B | 1,55B |
| Total Debt | 805,60M | 857,20M | 493,15M | 485,74M | 515,53M |
| Cash & Equivalents | 238,30M | 912,30M | 159,03M | 206,18M | 240,21M |
| Current Assets | 1,11B | 1,62B | 909,88M | 984,38M | 1,17B |
| Current Liabilities | 522,00M | 423,40M | 413,63M | 360,26M | 549,93M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#598 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026